Integrating digital PCR, specialized virology expertise, high-throughput automated workflows, culture-based approaches, and a CLIA laboratory to develop scalable and reproducible assays.
Our assays for target quantitation are critical components of cure programs for HIV-1 and infectious diseases. Accelevir and their collaborators have dedicated their lives to developing curative and targeted medicines for infectious diseases. Our novel assays are optimized to enable clinicians, researchers, and customers to access reproducible and highly quantitative tests.
Partnerships & Collaboration
Advancing next generation therapeutics is a team effort and Accelevir is committed to supporting our partners with innovative and scalable assay solutions. The convergence of scientific and operational capabilities enable us to support our partner development programs.
Clinical Trials & Clinicians
As a CLIA-certified, high-complexity molecular testing laboratory, we support the development, validation, implementation of In Vitro Diagnostics (IVD) and Laboratory Developed Tests (LDTs) across a variety of platforms.
Join the Team Leading the Change
We are looking for talented and creative problem solvers who are passionate about developing and performing assays to improve human health.